SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Enhertu Wins 2026 International Prix Galien Award for Best Biotechnology Product

Enhertu (trastuzumab deruxtecan) received the award, which the Galien Foundation presents every two years. It is the product’s second Prix Galien award, following its U.S. award for Best Biotechnology Product.

4568AZN
SquawkNews Desk

Related stories

Harris Teeter Launches New Rewards World Elite Mastercard The new card offers grocery savings and fuel discounts when shopping at Harris Teeter. M impact | EQUITY | Oct 30, 2026, 12:01 PM UTC Palo Alto Networks Advises Stockholders to Reject Tutanota Mini-Tender Offer Palo Alto Networks said it received notice of an unsolicited offer by Tutanota LLC to buy up to 250,000 shares of its common stock. H impact | EQUITY | Oct 30, 2026, 12:00 PM UTC Dominion Energy Q3 Profit Rises to $1.160 Billion Dominion Energy reported earnings of $1.30 per share, compared with $1.16 per share a year earlier. Profit totaled $1.160 billion, versus $1.006 billion. M impact | EQUITY | Oct 30, 2026, 12:00 PM UTC Simon Subsidiary Agrees to Acquire University Village Simon said a subsidiary entered into an agreement to acquire University Village, an open-air retail property. M impact | EQUITY | Oct 30, 2026, 12:00 PM UTC European session market picture: S&P 500 -1.11%, Nasdaq 100 -2.59%; EUR/USD +0.14%, WTI +2.01%, LLOY leads volume European session market picture. US index futures: S and P futures is down 1.11 percent, Nasdaq futures is down 2.59 percent, Dow futures is up 0.01 percent and Russell futures is M impact | EQUITY | Oct 30, 2026, 12:00 PM UTC Exxon Mobil Raises Stake in Mozambique LNG Project to 50% Exxon Mobil increased its stake in the planned project. M impact | EQUITY | Oct 30, 2026, 11:58 AM UTC